Core Insights - Venus Concept Inc. is expanding its international distributor network, with new partnerships in Taiwan and Colombia, and product certifications in India [1][2][3][4] Group 1: International Expansion - The company has partnered with Index International Ltd. in Taiwan and Quirugil S.A. in Colombia to enhance its distribution capabilities [1][2] - Quirugil operates with over 109 employees and has five branches in Colombia, providing a strong local network for Venus products [2] - The partnership with Spectra Medical Systems in India has led to the certification of several products, including Venus ARTAS iX and Venus Legacy, allowing for immediate distribution in a significant market [3][4] Group 2: Strategic Vision - The CEO of Venus Concept emphasized that these developments reflect the company's ongoing efforts to evolve its commercial strategy outside the U.S. to drive future growth and profitability [4] - The new agreements are expected to leverage local expertise and networks to supply aesthetic technologies to practitioners in key markets [4] - The company aims to utilize Paragon's established distribution presence in additional Asia-Pacific countries in the future [4] Group 3: Product Portfolio - Venus Concept offers a broad range of minimally invasive and non-invasive medical aesthetic technologies, reaching over 60 countries [6] - The product portfolio includes various aesthetic device platforms and hair restoration systems, such as NeoGraft® and the ARTAS iX® Robotic Hair Restoration system [6] - The company is backed by prominent healthcare industry growth equity investors, indicating strong financial support for its expansion efforts [6]

Company Overview - Venus Concept Inc. is a global leader in medical aesthetic technology, offering a wide range of minimally invasive and non-invasive products for aesthetic and hair restoration [4] - The company operates in over 60 countries and has 12 direct markets, showcasing its extensive reach in the industry [4] - Venus Concept's product portfolio includes various aesthetic device platforms and hair restoration systems, such as NeoGraft® and the ARTAS iX® Robotic Hair Restoration system [4] Financial Results Announcement - The company will release its third quarter financial results for fiscal year 2024 before the market opens on November 13, 2024 [1] - A conference call will be held at 8:00 a.m. Eastern Time on the same day to discuss the quarterly results, including a question and answer session [2] - For those unable to attend the live call, a replay will be available for two weeks, and the webcast will be archived on the company's investor relations website [3]

TORONTO, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that, on September 26, 2024, the Company exchanged $15.0 million of its senior debt held by affiliates of Madryn Asset Management, LP ("Madryn") for 203,583 shares of its Series Y preferred stock. Following this transaction, the Company had total debt obligations of approximately $34.6 million, down 25% from $46.0 million outstanding ...

Venus Concept (VERO) , a leader in medical aesthetic technology, is set to strengthen its international presence following the regulatory clearance from Australia's Therapeutic Goods Administration (TGA) to market its Venus Bliss MAX system. This flagship device, which integrates three innovative technologies, positions the company to capture a broader share of the aesthetic market across multiple regions. Likely Trend of VERO Stock Following the News Following the announcement, shares of the company moved ...

The Venus Bliss MAX is a 3-in-1 body shaping solution featuring three of Venus Concept's market leading technologies in one complete platform, including diode laser for Fat Reduction treatments, our proprietary (MP)2 applicator that combines Multi-Polar Radio Frequency with Pulsed Electro Magnetic Fields and advanced VariPulse™ technology for Cellulite Reduction and Skin treatments, and the Company's FlexMax EMS applicators for Muscle Toning and Conditioning. This communication contains "forward-looking sta ...

Management will host a conference call at 8:00 a.m. Eastern Time on August 13, 2024 to discuss the results of the quarter with a question and answer session. Those who would like to participate may dial 877-407-2991 (201-389-0925 for international callers) and provide access code 13747737. A live webcast of the call will also be provided on the investor relations section of the Company's website at ir.venusconcept.com. Venus Concept is an innovative global medical aesthetic technology leader with a broad pr ...

TORONTO, June 27, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announces the successful completion of its NEXThetics events held across several major cities in North America. NEXThetics events bring together Venus Concept's network of aesthetic leaders and practitioners and have seen a significant increase in popularity and attendance. Since our pilot events, the Company has hosted thousands of registrants, inclu ...

"NEXThetics Houston was an outstanding event, centering on the core principles of the latest technology, networking, and delivering an unparalleled experience among attendees," says Dr. Cheryl Haseeb of Pura Medical Aesthetics in Houston, Texas. "The attendees were highly engaged and eager to learn about the science behind this cutting-edge brand. They left energized and inspired to take their practice to the next level. It's truly inspiring to witness the positive impact this event has had on our professio ...

Venus Concept Inc. (NASDAQ:VERO) Q1 2024 Earnings Conference Call May 15, 2024 8:00 AM ET Company Participants Rajiv De Silva - Chief Executive Officer Hemanth Varghese - President and Chief Operating Officer Domenic Della Penna - Executive Vice President and Chief Financial Officer Conference Call Participants Marie Thibault - BTIG Jeffrey Cohen - Ladenburg Thalmann Operator Good day, ladies and gentlemen, and welcome to the First Quarter 2024 Earnings Conference Call for Venus Concept Inc. At this time, a ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission File Number: 001-38238 Venus Concept Inc. (Exact Name of Registrant as Specified in its Charter) (Stat ...